References
Collins, J.F. (2015). Long noncoding RNAs and hepatocellular carcinoma. Gastroenterology 148, 291–294.
Li, D., and Satomura, S. (2015). Biomarkers for hepatocellular carcinoma (HCC): an update. Adv Exp Med Biol 867, 179–193.
Qi, P., Zhou, X.Y., and Du, X. (2016). Circulating long non-coding RNAs in cancer: current status and future perspectives. Mol Cancer 15, 39.
Schlosser, K., Hanson, J., Villeneuve, P.J., Dimitroulakos, J., McIntyre, L., Pilote, L., and Stewart, D.J. (2016). Assessment of circulating LncRNAs under physiologic and pathologic conditions in humans reveals potential limitations as biomarkers. Sci Rep 6, 36596.
Shi, L., Peng, F., Tao, Y., Fan, X., and Li, N. (2016). Roles of long noncoding RNAs in hepatocellular carcinoma. Virus Res 223, 131–139.
Acknowledgements
This work was supported by the Natural Science Foundation of Beijing Municipality (CN7162185).
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Wang, C., Ren, T., Wang, K. et al. Identification of long non-coding RNA p34822 as a potential plasma biomarker for the diagnosis of hepatocellular carcinoma. Sci. China Life Sci. 60, 1047–1050 (2017). https://doi.org/10.1007/s11427-017-9054-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-017-9054-y